Brief: Krystal Biotech Provides Update On EMA’S Ongoing Regulatory Review
09/12/2024 21:20
Dec 9 (Reuters) - Krystal Biotech Inc KRYS.O :
* KRYSTAL BIOTECH PROVIDES UPDATE ON EMA’S ONGOING
REGULATORY
REVIEW OF B-VEC FOR DYSTROPHIC EPIDERMOLYSIS BULLOSA
* KRYSTAL BIOTECH INC: CHMP OPINION NOW EXPECTED IN 1Q 2025
* KRYSTAL BIOTECH INC: NO MAJOR OBJECTIONS OUTSTANDING;
CONTINUE
TO EXPECT GERMANY LAUNCH IN 2Q 2025
Source text: ID:nGNX63yTqH
Further company coverage: KRYS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Krystal Biotech
See all newsBrief: Krystal Biotech Announces Positive Clinical Data For New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression In Patients With Gorlin Syndrome
Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Krystal Biotech Q2 revenue rises on VYJUVEK strength
Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
Construction firm Tutor Perini jumps on S&P SmallCap inclusion